ALK-Abelló names SVP of R&D for North America and International Markets

Denmark-based allergy specialist ALK-Abelló (ALKB: DC) has appointed Hendrik Nolte as senior vice president of R&D for North America and International Markets, based in the USA.

Dr Nolte will be responsible for ALK’s R&D strategy in North America and International markets including China, and will work in collaboration with ALK’s partners for Russia, Japan, South-East Asia, Australia and New Zealand.

Henrik Jacobi, ALK’s executive vice president of R&D, said: “Hendrik’s reputation in the allergy immunotherapy field is unsurpassed and we welcome him to ALK as a key figure in the scale-up of our North American operations and an important contributor to our work to globalize the SLIT-tablet portfolio.”